We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A monthly roundup of key articles in other journals.
- Abstract
B I Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Convalescent plasma (CP) for COVID-19 respiratory illness (CONCOR-1) - a multicenter, international, open-label, randomized controlled trial - evaluated the effectiveness of CP in patients hospitalized with COVID-19. While CP transfusion has failed to demonstrate efficacy in large randomized clinical trials of hospitalized patients, smaller studies suggest some efficacy in older patients if administered soon after symptom onset.
- Subjects
LOW-molecular-weight heparin; CONVALESCENT plasma; COVID-19; ENDOTHELIUM diseases; BLOOD transfusion reaction
- Publication
Transfusion, 2021, Vol 61, Issue 12, p3289
- ISSN
0041-1132
- Publication type
Article
- DOI
10.1111/trf.16733